Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes

<strong>Background<br></strong> The evidence for whether ivermectin impacts recovery, hospital admissions, and longer-term outcomes in COVID-19 is contested. The WHO recommends its use only in the context of clinical trials. <br><strong> Methods<br></strong>...

Full description

Bibliographic Details
Main Authors: Hayward, G, Yu, L-M, Little, P, Gbinigie, O, Shanyinde, M, Harris, V, Dorward, J, Saville, BR, Berry, N, Evans, PH, Thomas, NP, Patel, MG, Richards, D, van Hecke, O, Detry, MA, Saunders, C, Fitzgerald, M, Robinson, J, Latimer-Bell, C, Allen, J, Ogburn, E, Grabey, J, de Lusignan, S, Hobbs, FR, Butler, CC
Other Authors: PRINCIPLE Trial Collaborative Group
Format: Journal article
Language:English
Published: Elsevier 2024

Similar Items